A groundbreaking discovery has shed light on a potential shield for liver health, especially for children at risk due to their mothers' dietary choices during pregnancy and breastfeeding. The stakes are high, as these dietary habits can set the stage for fatty liver disease later in life. But here's the good news: researchers at the University of Oklahoma have found a naturally occurring compound that might just lower this risk.
The compound, called indole, is produced by our friendly gut bacteria when they break down tryptophan, an amino acid found in everyday foods like turkey and nuts. This research adds to a growing body of knowledge focused on preventing metabolic dysfunction-associated steatotic liver disease (MASLD), a form of fatty liver disease that affects both adults and children, often progressing more rapidly in the latter and closely linked to diabetes.
Jed Friedman, Ph.D., director of the OU Health Harold Hamm Diabetes Center and professor of biochemistry and physiology at the OU College of Medicine, highlights the prevalence of MASLD in children, stating, "The prevalence of MASLD in children is about 30% in those with obesity and about 10% in children without obesity." He adds that the disease often goes unnoticed until a child exhibits liver-related symptoms, especially if the mother is obese or has a poor diet.
Friedman, alongside Karen Jonscher, Ph.D., associate professor of biochemistry and physiology at the OU College of Medicine, led a study published in eBioMedicine to explore the role of the microbiome in the development of fatty liver disease. They fed female mice a high-fat, high-sugar (Western-style) diet throughout pregnancy and lactation, with some mice also receiving indole. After weaning, the offspring were placed on a standard diet and later switched to a Western-style diet to induce fatty liver disease.
"A poor maternal diet can shape the infant's microbiome in harmful ways," Friedman explains, emphasizing the inheritance of the microbiome from mother to offspring.
The results were promising. Offspring born to mothers who received indole showed multiple health benefits, including healthier livers, less weight gain, lower blood sugar levels, and smaller fat cells, even when exposed to an unhealthy diet later in life. The researchers also observed the activation of a protective gut pathway involving the acyl hydrocarbon receptor (AHR).
Furthermore, the study found no increase in harmful long-chain ceramides in the liver, while levels of beneficial very long-chain ceramides rose. In a crucial experiment, gut bacteria from the protected offspring were transferred to other mice that had not received indole, resulting in less liver damage. This reinforces the idea that the microbiome plays a central role in protecting against fatty liver disease.
While the research was conducted in animals and cannot yet be directly applied to humans, it points to new strategies for early prevention of MASLD, which currently has no approved medications and relies solely on weight loss as a treatment option once the disease is established.
"Improving the mother's microbiome may be key to preventing MASLD in the offspring," Jonscher suggests.
This research opens up a new avenue for discussion and further exploration. What are your thoughts on the potential of gut bacteria and their compounds in preventing metabolic diseases? Could this be a game-changer in the fight against fatty liver disease? Share your insights and let's spark a conversation!
